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Epigenetic variation is implicated in a range of non-communicable diseases, including those of the eye. 
However, investigating the role of epigenetic variation in central tissues, such as eye or brain, remains 
problematic and peripheral tissues are often used as surrogates. In this study, matched human blood 
and eye tissue (n = 8) were obtained post-mortem and DNA methylation profiling performed on blood, 
neurosensory retina, retinal pigment epithelium (RPE)/choroid and optic nerve tissue using the Illumina 
Infinium HumanMethylation450 platform. Unsupervised clustering and principal components analysis 
revealed tissue of origin as the main driver of methylation variation. Despite this, there was a strong 
correlation of methylation profiles between tissues with >255,000 CpG sites found to have similar 
methylation levels. An additional ~16,000 show similarity across ocular tissues only. A small proportion 
of probes showing inter-individual variation in blood co-varied with eye tissues within individuals, 
however much of this variation may be genetically driven. An improved understanding of the epigenetic 
landscape of the eye will have important implications for understanding eye disease. Despite a 
generally high correlation irrespective of origin, tissue type is the major driver of methylation variation, 
with only limited covariation between blood and any specific ocular tissue.
The eye is the most specialised sensory organ in the human body. Light enters through the cornea and after 
passing through the pupil is finely focussed by the crystalline lens onto the neurosensory retina. Initiation of 
the phototransduction cascade converts the photonic energy into a neural signal, and following a high degree of 
pre-retinal processing, this signal is transferred via retinal ganglion cells to the brain1. Retinal ganglion cells exit 
the eye thorough the optic nerve to synapse in the mid-brain1. Stray light is absorbed by the retinal pigmented 
epithelium (RPE), which also serves a fundamental role in vitamin A cycling2. The high metabolic demand of 
phototransduction is ameliorated by the cavernous choroidal tissue which is located posterior to the RPE and 
receives the highest blood flow per tissue volume in the body2.
Dysfunction of almost any cellular component of the eye can lead to significant visual morbidity. Many oph-
thalmic diseases are known to have both heritable and environmental pathoaetiological factors3, and a greater 
understanding of the molecular mechanisms of ophthalmic disease have revolutionised therapy4,5. Although 
much insight into the genetic causes of ocular disease have been gained through well powered genome-wide 
association and linkage studies6, the precise means by which genetic variants and environmental stressors interact 
remain poorly understood. Such dynamic gene-environment interactions, many of which have downstream cel-
lular consequences, are potentially mediated by epigenetic variation established during development7, and under-
standing the epigenetic factors involved in ophthalmic disease may facilitate the development of novel disease 
screening and therapeutic avenues. Limited studies have suggested a role for epigenetic variation in diseases of the 
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eye, but these have generally been undertaken in non-ocular tissues and as such, the relevance to the pathology 
of interest remains unclear8–10.
Epigenetic variation has emerged as a major mediator of gene:environment interactions thought to underpin 
much of human disease. However, unlike genetic variation, epigenetic processes are dynamic both temporally 
and spatially, with each specific tissue type displaying a unique epigenetic profile. DNA methylation is by far the 
most widely studied epigenetic process due to its ease of measurement and high degree of stability in biological 
specimens, and many studies have begun to explore the link between DNA methylation variation and a range 
of exposures and disease outcomes. Although the field of epigenetic-epidemiology remains in its infancy, some 
compelling findings have emerged, particularly in relation to the effects of tobacco smoking exposure on DNA 
methylation profile in blood and buccal cells. A clearer understanding of the methylation landscape of tissues rel-
evant to specific conditions is required in order to gain insights into the relevance of measuring epigenetic profile 
in a proxy tissue such as blood or saliva11. Such knowledge gaps are common when dealing with living individuals 
and have only been directly assessed in limited postmortem studies. In neurological conditions this has been 
done by directly comparing matched blood and brain tissue12–14, but has yet to be investigated in matched blood 
and eye tissue.
The principal aim of this study was to investigate the methylation profiles of specific ocular tissues, and com-
pare this profile to matched peripheral blood. The overriding hypothesis was that there would be both tissue 
and individual specific methylation signatures, and that a blood DNA methylation profile could be identified 
for potential use as a proxy for the direct study of eye tissue, generally not possible in living humans. Herein, we 
determine the relative importance of ocular tissue methylation specificity at the genome-wide level, and quantify 
the number of sites that co-vary within an individual across neurosensory retinal, RPE/choroidal and optic nerve 
tissue.
Methods
Sample collection and processing. Whole blood from the subclavian vein and whole eyes were obtained 
post-mortem. The donors had no known ophthalmic disease. Donors previously diagnosed with disseminated 
cancer were excluded. Specimens from eight people were available. These donors were all male and the mean age 
at death was 60.6 (SD: 11.3; range 37–76) years (Supplementary Table 1).
Blood samples were collected in tubes containing EDTA. All ocular tissue was collected and stored within 
twelve hours post-mortem. A circumferential pars plana incision was made and the vitreous body discarded. 
The neurosensory retina was removed and the RPE and choroid were dissected free from the scleral wall. Dura 
matter was stripped from the anterior segment of optic nerve before storage. Samples with inadequate specimens, 
such as short optic nerve stump or macroscopically indistinct dissections, were discarded. Dissected ocular tissue 
was stored in QIAGEN Allprotect Tissue Reagent (QIAGEN, Hiden, Germany) and DNA extraction was subse-
quently performed using the QIAGEN DNeasy Blood & Tissue Kit (QIAGEN). Following bisulfite conversion 
using the Methyl Easy bisulphite modification kit (Human Genetic Signatures, Sydney, NSW, Australia), samples 
were hybridized to Illumina Infinium HumanMethylation450 (Illumina Inc, San Diego, CA, USA) BeadChips 
(HM450K) according to the manufacturer’s protocols. Array processing and Beadstudio analysis was conducted 
through the Australian Genome Research Facility (Melbourne, VIC, Australia).
This study was approved by the human research ethics committee of the University of Western Australia 
(RA/4/1/4805). Informed consent was obtained from next-of kin or powers of attorney. This study was conducted 
in accordance with the principles of the Declaration of Helsinki and its subsequent revisions.
Methylation data preprocessing. Quality control and background correction of the Beadstudio data was 
performed using the R programming software (version 3.2.1, http://cran.r-project.org/) ChAMP Bioconductor 
package, which utilises the minfi package15,16. Normalisation was performed on all samples using the beta-mixture 
quantile normalisation method, a comparably robust normalisation method which adjusts the beta-value distri-
bution of type II probes to resemble that of type I probes17. Probes that had a detection p-value greater than 0.01, 
probes that were cross-reactive, and probes that potentially contained SNPs of high minor allele frequency18, were 
removed from the dataset. As samples were all male, probes that hybridise to sex chromosomes were retained, 
leaving a total of 433,768 probes. Batch adjustment for samples was performed using the sva R package.
Data processing and statistical analysis. All statistical analysis was performed in R and the code for 
the analyses reported in this paper is available at https://github.com/hewittlab/Ocular-Methylation-Landscape. 
Unsupervised hierarchical clustering was first performed to investigate the relationships between samples. 
Methylation levels between individuals and tissues for all CpG sites were then compared using the Spearman cor-
relation coefficient. The mean β values for each probe and tissue across individuals was calculated and CpG sites 
were categorized as either hypomethylated (β ≤  0.2), having an intermediate level of methylation (0.2 < β  < 0.8), 
or hypermethylated (β ≥  0.8)19. The overlap of these categories between tissues were investigated using UpSet20.
Correlation between tissues. Subsequent analysis utilized probes that were ‘blood variable’, defined as having > 
5% methylation range within the inner 80th percentile of probes. The association of methylation levels between 
tissues within individuals was calculated for each CpG site using Spearman correlations. To establish the existence 
of an association in methylation levels between tissues, the correlation distribution was compared to a null corre-
lation distribution, which was simulated by permuting samples and calculating correlations between unmatched 
pairs. Paired t-tests with matched samples were used to identify the most similarly methylated probes between 
tissues. A ranked list according to p-value was generated and an adjusted p-value of 0.05 was used as a cutoff.
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Principal components analysis. To further investigate the structure of variation within the dataset, principal 
components analysis was performed on normalised M-values. Principal components were analysed for correla-
tion with sample traits (tissue type, individual, age at death, cause of death, known co-morbidities, preservation 
time interval), using both linear regression and ANOVA. Probes that are associated with trait-related principal 
components contribute to the pattern of variation and likely vary across the trait.
As we were mainly interested in inter-individual differences across tissue type, probes that were highly associ-
ated with individual-associated principal components (|r| > 0.5) were selected for further analysis. Four principal 
components were found to vary between individuals only at a p < 0.10 level, accounting for 10.8% of the total 
variation. Hierarchical clustering was performed with probes related to these principal components, both com-
bined and separately, and with and without the removal of tissue-specific probes. As there was little gene overlap 
between individual-specific and tissue-specific probes, the removal of tissue-specific probes had no significant 
effect on clustering. Only one principal component was significantly associated with inter-individual difference 
at p < 0.05. Probes that correlate with this principal component (PC13) were then compared with probes that 
co-vary between tissues. Individual specific probes were defined as those which co-vary across tissues within an 
individual and were identified by PCA. In contrast, tissue specific probes were defined as significantly different 
across tissues from different individuals and were identified using Limma Bioconductor package21.
Gene annotation and genomic enrichment. Probes were categorised into genomic features and CpG island fea-
tures according to the annotation file provided for Illumina. Enrichment within each category was investigated 
for all probes, blood variable probes, blood variable probes that correlate with each eye tissue (|r| > 0.5, p < 0.05), 
and probes that correlate with individual-related principal components.
Gene ontology and Pathway analysis. Ingenutity Pathway Analysis (IPA) was used to investigate cellular 
pathways subject to DNA methylation variation. Gene ontology enrichment analysis was assessed using the 
PANTHER Overrepresentation Test (release 20160715) as part of the Gene Ontology Consortium (www.geneon-
tology.org). HM450K probes located in a gene, or within 2 kb of the transcription start site showing differential 
methylation were assigned to the annotated gene. Genes on the HM450K array were used as the background 
list against which a target list were analysed. Gene with probes found to have variation exclusively associated 
with individuals at p < 0.05, were explored for previous association with eye disease. Gene previously impli-
cated in eye disease were retrieved from the Retinal Information Network (https://sph.uth.edu/Retnet/; accessed 
28/11/2016) and the NHGRI-EBI Catalog of published genome-wide association studies (https://www.ebi.ac.uk/
gwas/; accessed 28/11/2016)22,23.
Results
Sources of variation within the dataset. A total of 27709 and 8337 probes, which either contain SNPs 
or align to multiple locations respectively, were removed from the analysis24. Following quality control and data 
normalization, DNA methylation values from a total of 433,768 probes were available for use in analysis. As antic-
ipated, unsupervised hierarchical clustering revealed tissue type as the main driver of variation within the data-
set, blood had the most distinct methylation profile, while RPE/choroid and optic nerve were the most similar 
(Fig. 1). Multidimensional Scaling plot visualisation of the 1,000 most variable probes highlighted the similarity 
of RPE/choroid and optic nerve methylation profiles relative to retina, with blood the most dissimilar in methyl-
ation profile (Supplementary Figure 1).
To further dissect the source(s) of methylation variation within the dataset, we performed principal compo-
nent analysis. As expected, most of the variation within the dataset (55.84%) was due to tissue type, with the first 
four principal components (PCs) all associated with tissue of origin at p < 0.05 (Fig. 2). The only PC of variation 
that exclusively associated with individuals at p < 0.05 was PC13, comprising 802 probes that account for 1.87% 
of the variance within the dataset (Supplementary Table 2). Hierarchical clustering using probes associated with 
PC13 showed a clear separation of most individuals as predicted, despite very similar methylation levels across 
individuals overall (Supplementary Figure 2). Correlation analysis confirmed that PC13 was not related to any 
measured phenotype, such as age at death and cause of death (not shown).
In order to test the likely role of underlying genetics in the variation seen in PC13 probes, we carried out a 
limited literature search for evidence of any SNP-association, or mQTL for the probes a subset of PC13 probes. Of 
the 50 top probes tested in this manner, we were able to identify evidence for the potential influence of underlying 
genetic variation on methylation at 2725,26. Thus, it is likely that much of inter individual variation seen in PC13 is 
likely attributable (at least in part) to underlying genetics rather than being environmentally driven in isolation.
Correlation of methylation values within and between tissues. Despite this discrete clustering, and 
reflecting the large number of CpG sites analysed, there was generally a strong correlation between methylation 
across all samples, with a median Spearman correlation of 0.914 (range: 0.819–0.987). Blood methylation profile 
had the strongest correlation with RPE/choroid (median r = 0.913, range: 0.892–0.939; not shown), followed by 
optic nerve (median, range) (not shown) and retinal tissue (median r = 0.850, range: 0.819–0871; not shown),.
Methylation β -values were bimodally distributed, with the majority of sites being commonly hypomethylated 
(β ≤ 0.2) or hypermethylated (β ≥ 0.8) across all tissues (Supplementary Figure 3). In order to explore this fur-
ther, we divided probes into three categories of hypo (β ≤ 0.2), intermediate (0.2 < β < 0.8) and hypermethylated 
(β ≥ 0.8) and then assessed the degree of overlap in each class of probe across all tissues tested. This approach 
confirmed that the majority of methylation is relatively consistent across all tissues, though considerable evidence 
of tissue-of-origin methylation levels is also present within all 3 broad methylation classes (Fig. 3). Interestingly, 
each of the ocular tissues examined also shared a uniquely overlapping set of methylation levels with blood rather 
than other eye tissues (Fig. 3).
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We were primarily interested in identifying CpG sites where inter-individual variation in blood was also asso-
ciated with inter-individual differences in eye methylation. Such probes may represent reliable proxy measures for 
variation in ocular methylation, measurable in peripheral blood. To investigate this, pairwise correlation analysis 
was performed for each probe within a subset identified as variable in blood across individuals, defined as those 
for which the inter-individual methylation difference between the 10th and 90th percentiles was > 5% (224,417 
probes in total). The distribution of correlations between matched samples was compared with a randomly per-
muted distribution (i.e. null) to establish the degree of relatedness between blood and eye methylation levels. 
Significant differences were found between the true and null distributions (Wilcoxon rank test p < 2.2 × 10−16 for 
all tissues (not shown)). Interestingly, most of the probes that were correlated or anti-correlated (Spearman r > 0.5, 
Figure 1. Sample relationships based on methylation at 433,768 HM450K probes shows tissue of origin as 
the main driver of variability within the dataset. (A) Hierarchical clustergram across all samples. Individuals 
are represented by their corresponding code followed by B (blood), C (RPE/choroid), R (retina), or O (optic 
nerve) to identify tissue type. (B) Heatmap of the 10,000 most variable HM450K probes. Probes are plotted 
on the x-axis, and individual tissue samples are plotted on the y-axis. Completely unmethylated (0 or 0% 
methylation) probes are represented as blue, and completely methylated (1 or 100% methylated) probes are 
represented as red.
Figure 2. ANOVA analysis of principal components (PC) with sample traits. (A) Scree plot showing the 
proportion of total variation in the dataset captured by each of the first 29 PC. (B) Significance of association 
between each PC and individual, tissue of origin, eye vs non-eye (tissuebinary), and array chip. The first 4 PCs 
show a significant association with tissue of origin as anticipated, whereas PC13 captures the majority of inter-
individual variation.
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p < 0.05) between blood and eye tissues within an individual were unique for each pairwise tissue comparison, 
with only 122 probes commonly correlated with blood across all three eye tissues. Hierarchical clustering using 
these commonly variable probes revealed that retina and blood samples still cluster primarily by tissue, whereas 
RPE/choroid and optic nerve samples cluster by individual as opposed to tissue type (Supplementary Figure 4). 
Thus, these probes in isolation are of limited utility in inferring general ocular methylation status from blood.
Genomic context of variable probes.  Compared to the overall distribution of probes, those showing 
inter-individual variation in blood were enriched for intergenic regions and CpG ‘open seas’ (Fig. 4). The genomic 
distribution of PC13-related probes appeared to be closer to the overall distribution, rather than blood-variable 
probes, being enriched at sites within 200 bp of transcription start sites, and also in CpG islands. This suggests that 
probes that vary between individuals do not necessarily co-vary between tissues types within an individual. Of 
802 probes associated with PC13, 281 showed variable methylation in blood of different individuals, and of those, 
115 showed correlated methylation with one or more eye tissues within an individual.
Gene Pathway and ontology Analysis.  The 802 probes associated with PC13 were linked to 541 genes 
and 25 of these have been previously implicated in eye disease (Supplementary Table 3). IPA analysis identified 
an overrepresentation of canonical pathways, ‘IL-1 Signaling’, ‘Molecular Mechanisms in Cancer’, ‘Protein Kinase 
A, Relaxin and α -Adrenergic signaling’. Gene Ontology analysis identified enrichment of cell cycle regulators, 
protein modifiers (particularly kinases) and genes involved in RNA metabolism. There was no enrichment for 
specific pathways in the genes associated with the 115 probe subset that showed a correlation with one or more 
eye tissue.
Discussion
Direct comparison of ocular tissue and peripheral blood samples from the same people revealed tissue of origin 
as the main driver of methylation variation. However, despite these distinct signatures, there was a strong corre-
lation of methylation profiles between tissues, with > 255,000 CpG sites found to have similar methylation levels 
and an additional ~16,000 sites found to show similarity across ocular tissues only. A small proportion of probes 
showing inter-individual variation in blood co-varied with eye tissues within individuals, however a large propor-
tion of this variation appears may be genetically driven.
Much of the application of epigenome-wide association studies (EWAS) to human conditions in recent years 
has been predicated on the assumption that accessible tissues show evidence of epigenetic variation associated 
with an exposure of interest, or reflective of less accessible tissues directly implicated in specific phenotypes11,27. 
Exceptions to this include the use of tissue biopsies from adults (e.g. adipose or muscle in metabolic conditions), 
tissue removed during surgery for clinical purposes (e.g. heart surgery and cardiovascular disease) and the use of 
tissues obtained postmortem (particularly of CNS origin)28. The latter are particularly important in allowing the 
delineation of the baseline epigenetic profile of tissues not accessible in living individuals and for comparing such 
a profile to more accessible tissues such as blood or saliva11,27.
The potential for epigenetic variation to play a role in diseases of the eye has been suggested for several years, 
with various explorations in blood or saliva in individuals with conditions such as AMD8,9. Recently, the poten-
tial for DNA methylation to play a role in AMD has been directly investigated through the genome-wide DNA 
methylation profiling of blood from AMD patients and controls. Small but replicable differences in DNA meth-
ylation were identified in the blood of neovascular AMD patients near the age-related maculopathy susceptibility 
2 (ARMS2), gene, previously linked to AMD in genome-wide association studies10. Interestingly, an integrated 
analysis of blood and retina further identified consistent DNA methylation variation in the protease serine 50 
(PRSS50) gene10.
Figure 3. Overlap between tissues of probes designated hypomethylated (< 20%; A), intermediate (20–80%; B) 
and hypermethylated (> 80%; C). Whereas the majority of probes showing conserved methylation across tissues 
are either hyper- or hypomethyalated, tissue specific methylation is more likely to be at intermediate levels.
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Genetic variation at methylation quantitative trait loci (mQTLs) plays a major role in shaping the human DNA 
methylation profile, including the potential modulation of the effects of environmental exposures on methylation 
variation. Although some mQTLs are likely tissue specific in their influence on methylation, others are likely con-
served across tissues with their effects measureable in tissues such as blood. Evidence in support of a combined 
effect of genetic and epigenetic variation has also been implicated in AMD with evidence of an association with 
underlying genotype of the risk SNP rs10490924 with disease-associated variation in ARMS2 methylation10.
In many large epidemiological studies, whole blood is the only biological material that has been archived. 
The extent to which the DNA methylation patterns of easily accessible tissues like whole blood represent the 
epigenetic phenotype in inaccessible tissues is unclear, although recent studies are showing a certain degree of 
concordance. Epigenetic variation arising before disease could be inherited and thus be present in all adult tissues, 
or it could arise stochastically during the lifecourse and be limited to one, or a few tissues. Epigenetic variation 
can also be environmentally induced by life-style related factors, such as diet or smoking. In support of this, a 
panel of metastable epialleles has recently been described in humans that show inter-individual variation appar-
ently independent of tissue of origin29. Such loci have considerable potential to act as epigenetic ‘sensors’ of past 
environmental influence/exposure.
There are some caveats to the use of peripheral blood leukocytes to study DNA methylation profiles. Firstly, 
like neurosensory retinal and RPE/choroidal tissue, peripheral blood comprises a heterogeneous cell population. 
Therefore, any observed variation in DNA methylation assessed in whole blood may reflect small changes in the 
proportions of differentially methylated cell types that may in turn vary between individuals30. A further limita-
tion involves the issue of timing. It is now apparent that the DNA methylation of whole blood is altered with age-
ing and therefore samples taken from the same individual might be different if taken a few years apart. Equivalent 
data are generally not available for more central tissues of CNS or ocular origin. This has considerable potential to 
confound interpretation of EWAS studies.
It is also noteworthy that our methylation profiling based on the HM450K beadchip evaluates only a biased 
subset of potential methylation sites, and that a similar study performed with other technology such as whole 
Figure 4. Distribution of mean methylation according to genomic feature (A) or CpG density relative to 
CpG islands (B). Classes B1, B2 and B3 correspond to hypomethylated, intermediate and hypermethylated 
probes in blood with E1, E2 and E3, the equivalent categories in eye tissue. Mean methylation was calculated 
as the average methylation level across each individual probe within a specific dataset used for the blood-eye 
comparison shown. The percentage of total probes is displayed. (A) The majority of probes are located in gene 
bodies or intergenic regions and show hyper- or intermediate methylation in both eye and blood. In contrast, 
a larger proportion of probes in the 5’UTR, 1st Exon or TSS regions are hypomethylated in both blood and eye 
tissues. (B) As anticipated, the majority of CpG island-associated probes are hypomethylated in blood and eye 
tissue, whereas CpG island Shores, Shelves and Open Sea are more highly methylated in both tissues. Data are 
shown for (i) all probes, (ii) probes showing inter-individual variation in blood, (iii–v) blood variable probes 
highly correlated with RPE/choroid, optic nerve or retina. and (vi) PC13-specific probes (all on the X-axis). The 
latter are primarily located within 200 bp of gene transcription start sites in CpG island regions.
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genome bisulfite sequencing may identify a greater level of correlation between blood and ocular tissue31. Further, 
although probes known to contain SNPs or which align to multiple locations were removed16, it is certainly pos-
sible that rare or uncommon genetic variants could contribute to individual variation we identified. Finally, the 
lack of detailed recent ophthalmic clinical details may have further confounded our findings.
In summary, we defined the DNA methylation profile of three ocular tissues and compared these directly 
to matched peripheral whole blood from the same individuals. Despite a largely concordant methylation pro-
file, only limited instances of correlated variation between tissues within specific individuals were observed. 
Collectively, our data support recent findings in similar analyses of the brain that suggested EWAS approaches 
using whole blood for disorders of the brain are likely to be of only limited utility for discovery type approaches 
aimed at unraveling disease aetiology12. Nevertheless, as with our findings in the eye, there are a proportion of 
sites where inter-individual variation is correlated between whole blood and brain, highlighting the utility (albeit 
limited with the current platform) of using a blood-based EWAS to identify potential biomarkers of disease of 
more central tissues such as the brain and the eye.
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